African Pharmaceutical Review.

African Pharmaceutical Review.

Pharverse
Trending
Lonza acquires Roche’s biologics site for $1.2 billion
Using AI to tailor drugs for Africa
NAFDAC boss: How local production is the answer to high cost of medicines

News

View All
FDA accepts for review GSK’s new fully liquid shingles vaccine

FDA accepts for review GSK’s new fully liquid shingles vaccine

WHO prequalifies diagnostic test to minimize hemolysis from antimalarial drugs

WHO prequalifies diagnostic test to minimize hemolysis from antimalarial drugs

GSK’s investigational antibody-drug conjugate achieves breakthrough therapy designation

GSK’s investigational antibody-drug conjugate achieves breakthrough therapy designation

Key Alzheimer’s Disease Treatment Approved in China

Key Alzheimer’s Disease Treatment Approved in China

Roche launches new innovative mass spectrometry solution

Roche launches new innovative mass spectrometry solution

GSK’s fully liquid meningococcal vaccine approved in Europe

GSK’s fully liquid meningococcal vaccine approved in Europe

Novartis’ innovative breast cancer medicine gets approval in Europe

Novartis’ innovative breast cancer medicine gets approval in Europe

AstraZeneca’s first in class therapy shows efficacy in metastatic prostate cancer

AstraZeneca’s first in class therapy shows efficacy in metastatic prostate cancer

FDA accepts for review GSK’s new multiple myeloma therapy

FDA accepts for review GSK’s new multiple myeloma therapy

Japan approves first RSV vaccine for adults aged 50 -59

Japan approves first RSV vaccine for adults aged 50 -59

Second mpox vaccine receives WHO emergency use approval

Second mpox vaccine receives WHO emergency use approval

Lonza completes first GMP product batch at new mammalian manufacturing facility

Lonza completes first GMP product batch at new mammalian manufacturing facility

Drug shows reduced risk of progression to type 2 diabetes in pre-diabetics

Drug shows reduced risk of progression to type 2 diabetes in pre-diabetics

Selumetinib shows efficacy in adult patients with neurofibromatosis

Selumetinib shows efficacy in adult patients with neurofibromatosis

AbbVie’s emraclidine fails to demonstrate efficacy in management of schizophrenia

AbbVie’s emraclidine fails to demonstrate efficacy in management of schizophrenia

FDA to remove phenylephrine as an active ingredient for nasal congestion

FDA to remove phenylephrine as an active ingredient for nasal congestion

Anti-asthmatic therapy shows efficacy in treatment of chronic rhinosinusitis with nasal polyps

Anti-asthmatic therapy shows efficacy in treatment of chronic rhinosinusitis with nasal polyps

9 African countries most affected by the mpox outbreak get vaccines allocation

9 African countries most affected by the mpox outbreak get vaccines allocation

Regeneron’s dupilumab has achieved approval in Europe as the first treatment approved for children with eosinophilic esophagitis

Regeneron’s dupilumab has achieved approval in Europe as the first treatment approved for children with eosinophilic esophagitis

Two biotechnology firms partner to develop new AI-powered biopharmaceuticals

Two biotechnology firms partner to develop new AI-powered biopharmaceuticals

AbbVie and EvolveImmune Therapeutics partner to innovate new cancer biotherapies

AbbVie and EvolveImmune Therapeutics partner to innovate new cancer biotherapies

Bayer and Liveo Research unveil innovative, eco-friendly blister packaging solution

Bayer and Liveo Research unveil innovative, eco-friendly blister packaging solution

GSK acquires new investigational therapy targeted for lupus treatment

GSK acquires new investigational therapy targeted for lupus treatment

AstraZeneca’s brand of benralizumab gains approval in Europe

AstraZeneca’s brand of benralizumab gains approval in Europe

AbbVie set to enhance its CNS product line with acquisition of Aliada therapeutics

AbbVie set to enhance its CNS product line with acquisition of Aliada therapeutics

Organon finalizes acquisition of Dermavant for up to $1.2 billion

Organon finalizes acquisition of Dermavant for up to $1.2 billion

Regeneron’s targeted therapy shows promise in chronic spontaneous urticaria treatment

Regeneron’s targeted therapy shows promise in chronic spontaneous urticaria treatment

Pfizer’s RSV vaccine gets FDA nod for adults with increased risk of disease

Pfizer’s RSV vaccine gets FDA nod for adults with increased risk of disease

Oral semaglutide shows reduction in risk of major adverse cardiovascular events in diabetic patients

Oral semaglutide shows reduction in risk of major adverse cardiovascular events in diabetic patients

Lonza extends partnership with biopharmaceutical company for supply of antibody drug conjugates

Lonza extends partnership with biopharmaceutical company for supply of antibody drug conjugates

WHO declares Egypt malaria-free

WHO declares Egypt malaria-free

First once-daily subcutaneous prophylactic treatment for hemophilia recommended for European approval

First once-daily subcutaneous prophylactic treatment for hemophilia recommended for European approval

Innovative subcutaneous combination therapy receives approval for Parkinson's disease

Innovative subcutaneous combination therapy receives approval for Parkinson's disease

GSK’s first-in-class antibiotic with new mechanism of action approved for priority review

GSK’s first-in-class antibiotic with new mechanism of action approved for priority review

Lonza Finalizes Expansion of Its New Drug Product Services Facility

Lonza Finalizes Expansion of Its New Drug Product Services Facility

Big step in breast cancer treatment as Roche’s new therapy gains FDA approval

Big step in breast cancer treatment as Roche’s new therapy gains FDA approval

AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule

AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule

Win for Africa as Gilead grants generic licensing for innovative HIV medicine

Win for Africa as Gilead grants generic licensing for innovative HIV medicine

Lonza acquires Roche’s biologics site for $1.2 billion

Lonza acquires Roche’s biologics site for $1.2 billion

Africa to receive one million mpox vaccines through new UNICEF deal

Africa to receive one million mpox vaccines through new UNICEF deal

FDA approves drug with new pharmacological approach to schizophrenia treatment

FDA approves drug with new pharmacological approach to schizophrenia treatment

Lonza Secures Long-Term Agreement to Supply Critical Cell Therapy for Sickle Cell Treatment

Lonza Secures Long-Term Agreement to Supply Critical Cell Therapy for Sickle Cell Treatment

GSK receives Positive EU opinion for fully liquid meningococcal vaccine

GSK receives Positive EU opinion for fully liquid meningococcal vaccine

AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment

AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment

Team Europe, Rwanda sign agreements worth €40m to strengthen Rwanda’s pharma sector

Team Europe, Rwanda sign agreements worth €40m to strengthen Rwanda’s pharma sector

Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.

Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.

China taps into Africa through strategic deal with Nigerian firm to fight HIV

China taps into Africa through strategic deal with Nigerian firm to fight HIV

Roche’s Xofluza reduces transmission of flu viruses, global trial shows

Roche’s Xofluza reduces transmission of flu viruses, global trial shows

Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis

Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis

Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.

Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.

Big step as WHO prequalifies the first vaccine against mpox

Big step as WHO prequalifies the first vaccine against mpox

Eli Lilly, Eva Pharma partner to enhance access to key immunomodulatory drug across Africa.

Eli Lilly, Eva Pharma partner to enhance access to key immunomodulatory drug across Africa.

Nigeria becomes first African country to receive mpox vaccines

Nigeria becomes first African country to receive mpox vaccines

Nigeria Issues Five Alerts on Confirmed Counterfeit Medicines in August

Nigeria Issues Five Alerts on Confirmed Counterfeit Medicines in August

WHO invites Mpox vaccine manufacturers to apply for emergency use listing

WHO invites Mpox vaccine manufacturers to apply for emergency use listing

J&J agrees to drop price of TB drug in South Africa after intense pressure

J&J agrees to drop price of TB drug in South Africa after intense pressure

SAHPRA signs MoU with Rwanda Food and Drug Authority

SAHPRA signs MoU with Rwanda Food and Drug Authority

Pfizer Expected To Offload £2 billion Worth Of Haleon Shares

Pfizer Expected To Offload £2 billion Worth Of Haleon Shares

The African Pharmaceutical Technology Foundation Receives $12million To Operationalize And Recruit Pharma Expertise

The African Pharmaceutical Technology Foundation Receives $12million To Operationalize And Recruit Pharma Expertise

New Country Ratifies The African Medicines Agency Treaty

New Country Ratifies The African Medicines Agency Treaty

Uganda set to roll out new injectable HIV prevention drug

Uganda set to roll out new injectable HIV prevention drug

Johnson & Johnson Makes Major Rebrand To Signal New Era

Johnson & Johnson Makes Major Rebrand To Signal New Era

Cipla expands in South Africa with acquisition of Actor Pharma for $49million

Cipla expands in South Africa with acquisition of Actor Pharma for $49million

South Africa : Pharmacists Now Allowed To Prescribe HIV/TB Medicines

South Africa : Pharmacists Now Allowed To Prescribe HIV/TB Medicines

Nigeria: Pfizer seeks collaboration in the fight against counterfeit medicines

Nigeria: Pfizer seeks collaboration in the fight against counterfeit medicines

Gambia: 70 children lost lives due to substandard cough syrups

Gambia: 70 children lost lives due to substandard cough syrups

Daewoong Pharmaceutical’s Fexuprazan looks into Africa

Daewoong Pharmaceutical’s Fexuprazan looks into Africa

Malaria : 12 African countries to benefit from life saving vaccine

Malaria : 12 African countries to benefit from life saving vaccine

Nigeria sets pace with rollout of new meningitis vaccine

Nigeria sets pace with rollout of new meningitis vaccine

New Nation Has Officially Ratified The African Medicines Agency Treaty

New Nation Has Officially Ratified The African Medicines Agency Treaty

GSK raises £1.25 billion from discounted sale of Haleon shares

GSK raises £1.25 billion from discounted sale of Haleon shares

New African Nation Reaches WHO Maturity Level 3 In Medicines Regulation

New African Nation Reaches WHO Maturity Level 3 In Medicines Regulation